Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 49 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Smyth A, Teo KK, Rangarajan S, O'Donnell M, Zhang X, Rana P, Leong DP, Dagenais G, Seron P, Rosengren A, Schutte AE, Lopez-Jaramillo P, Oguz A, Chifamba J, Díaz R, Lear S, Avezum A, Kumar R, Mohan V, Szuba A, Wei L, Yang W, Jian B, McKee M, Yusuf S, PURE Investigators. Alcohol consumption and cardiovascular disease, cancer, injury, admission to hospital, and mortality: a prospective cohort study. Lancet 2015;386:1945-54. [Ref.ID 99672]
2. Cita con resumen
Royo-Bordonada MA, Lobos JM, Brotons C, Villar F, de Pablo C, Armario P, Cortés O, Gil Nuñez A, Lizcano A, de Santiago A, Sans S. El estado de la prevención cardiovascular en España. Med Clin (Barc) 2014;142:7-14. [Ref.ID 97015]
3. Cita con resumen
Holmberg SD, Sprading PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013;368:1859-61. [Ref.ID 95535]
4. Cita con resumen
Reeves A, Stuckler D, McKee M, Gunnell D, Chang S-S, Basu S. Increase in state suicide rates in the USA during economic recession. Lancet 2012;380:1813. [Ref.ID 94121]
5. Cita con resumen
Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and association with all-cause and CVD mortality among US adults. JAMA 2012;307:1273-83. [Ref.ID 92567]
6. Cita con resumen
Scurti V, Romero M, Tognoni G. A plea for a more epidemiological and patient-oriented pharmacovigilance. Eur J Clin Pharmacol 2012;68:11-9. [Ref.ID 92256]
7.Tiene citas relacionadas
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, Zumla A. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 2010;375:1920-37. [Ref.ID 88609]
8.Tiene citas relacionadas
Harries AD, Zachariah R, Corbett EL, Lawn SD, Santos-Filho ET, Chimzizi R, Harrington M, Maher D, Williams BG, De Cock KM. The HIV-associated tuberculosis epidemic - when will we act?. Lancet 2010;375:1906-19. [Ref.ID 88608]
9.Tiene citas relacionadas Cita con resumen
Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, Kent CK, Finelly L, Ferguson NM. Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med 2009;361:2619-27. [Ref.ID 87403]
10. Cita con resumen
Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 2009;124:362-70. [Ref.ID 86442]
11.
Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, and the EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33. [Ref.ID 86065]
12.Tiene citas relacionadas
Brekke M, Gjelsvik B. Effectiveness of secondary prevention programmes in CHD. Authors' reply. Lancet 2009;373:1671. [Ref.ID 85869]
13.Tiene citas relacionadas
Clark AM, Dalal HM, Dafoe W, Stone JA, Lewin RJP. Effectiveness of secondary prevention programmes in CHD. Lancet 2009;373:1671. [Ref.ID 85868]
14.Tiene citas relacionadas Cita con resumen
Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U, for the EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009;373:929-40. [Ref.ID 85473]
15.Tiene citas relacionadas Cita con resumen
Brekke M, Gjelsvik B. Secondary cardiovascular risk prevention - we can do better. Lancet 2009;373:873-5. [Ref.ID 85465]
16.Tiene citas relacionadas
Weinstock DM, Zuccotti G. The evolution of influenza resistance and treatment. JAMA 2009;301:1066-9. [Ref.ID 85429]
17.Tiene citas relacionadas Cita con resumen
Gooskens J, Jonges M, Claas ECJ, Meijer A, van den Broek PJ, Kroes ACM. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. JAMA 2009;301:1042-0146. [Ref.ID 85427]
18.Tiene citas relacionadas Cita con resumen
Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St. George K, Epperson S, Brammer L, Klimov AI, Bressee JS, Fry AM, for the Oseltamivir-Resistance Working Group. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 2009;301:1034-41. [Ref.ID 85426]
19.
Basterra-Gortari FJ, Martínez-González MA. Comparación de la prevalencia de diabetes mellitus entre comunidades autónomas. Med Clin (Barc) 2007;129:716. [Ref.ID 81682]
20. Cita con resumen
Hill K, López AD, Shibuya K, Jha P, on behalf of the Monitoring of Vital Events (MoVE) writing group. Interim measures for meeting needs for health sector data: births, deaths, and causes of death. Lancet 2007;370:1726-35. [Ref.ID 81563]
Seleccionar todas
 
 1 a 20 de 49 siguiente >>